Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1886 of 6351
-
Special foods could make Low-Protein diets easier for kidney patients
Disease control CompletedThe KDOQI 2020 - Clinical practice guideline for nutrition in chronic kidney disease (CKD) -recommends protein restriction to reduce the risk of end-stage renal disease/death and improve quality of life, a low protein diet providing 0.55-0.60g dietary protein/ kg body weight/day …
Sponsor: Dr. Schär AG / SPA • Aim: Disease control
Last updated Aug 19, 2026 00:00 UTC
-
New combo therapy shows promise for Tough-to-Treat lymphoma
Disease control CompletedThe purpose of this study is to evaluate the preliminary efficacy, safety, and pharmacokinetics of glofitamab (glofit) in combination with rituximab plus ifosfamide, carboplatin, and etoposide (R-ICE) in participants with relapsed or refractory (R/R) diffuse large B-cell lymphoma…
Phase 1 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
MRI and microbes: a new way to predict rectal cancer outcomes?
Knowledge-focused CompletedThis study will focus on two points: 1. To determine if response to neoadjuvant chemoradiotherapy treatment in rectal cancer can be predicted by analysing data from Fast Field Cycling imaging (FFC), a novel type of MRI technique. 2. To determine if there is evidence that the bac…
Sponsor: University of Aberdeen • Aim: Knowledge-focused
Last updated Sep 02, 2026 00:00 UTC
-
Experimental combo aims to tackle tough lymphomas
Disease control Recruiting nowThis phase I trial tests the safety, side effects, and best dose of nivolumab in combination with ASTX727 in treating B-cell lymphoma that has come back (relapsed) or does not respond to treatment (refractory). Immunotherapy with monoclonal antibodies, such as nivolumab, may help…
Phase 1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
New program aims to help hospitalized smokers kick the habit for good
Disease control Recruiting nowTobacco use remains the leading cause of death in the United States and contributes to more than 7 million hospitalizations annually. Being admitted to the hospital offers the perfect opportunity to support smoking cessation. Patients are motivated to quit because of their curren…
Phase 2 • Sponsor: Baystate Medical Center • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
A moment of gratitude could protect the hearts of community health heroes
Disease control CompletedCommunity service providers (CSPs), such as promotores and other community health staff, play an essential role in preserving health and treating disease in underserved Hispanic/Latinx (HL) communities with disproportionately high rates of cardiometabolic (CM) disease. Although e…
Sponsor: University of California, Irvine • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
Could a tiny electric zapper beat pills for IBS pain?
Symptom relief Recruiting nowThis study will assess the efficacy of two active treatments with TEA and a chemical neuromodulator (escitalopram aka Lexapro) versus a sham comparator or control group on abdominal pain.
Phase 2/3 • Sponsor: University of Michigan • Aim: Symptom relief
Last updated Jun 27, 2026 07:54 UTC
-
Muscle quality on MRI may foretell liver transplant success
Knowledge-focused Recruiting nowProspective natural history pilot study to explore the link between muscle composition using an MRI-based Muscle Assessment Score (MAsS) and adverse outcomes in liver transplant candidates.
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Aug 07, 2026 00:00 UTC
-
A simple card game could transform diabetes care
Symptom relief CompletedGlycemic control is often the main indicator of successful diabetes care, but a singular focus on glycemic control may lead to patients' overall health and wellbeing being overlooked or undervalued. The investigators have previously developed an intervention comprised of (a) a se…
Sponsor: Yale University • Aim: Symptom relief
Last updated Aug 08, 2026 00:03 UTC
-
Mother's scent may calm preterm infants' breathing
Disease control CompletedApnea of prematurity is one of the most common complications in preterm infants hospitalized in neonatal intensive care units. This randomized controlled trial was conducted to evaluate the effect of maternal odor exposure as a developmental care intervention on apnea frequency, …
Sponsor: Ankara Yildirim Beyazıt University • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
Could a tiny ear device ease autism symptoms?
Symptom relief Recruiting nowIn this study, investigators will examine the treatment effects of transcutaneous electrical nerve stimulation with different stimulation frequencies on individuals with autism.
Sponsor: Massachusetts General Hospital • Aim: Symptom relief
Last updated Jul 19, 2026 00:00 UTC
-
Could a diabetes drug help dental implants fuse better?
Disease control CompletedTo evaluate, by standardized radiographic follow-up, whether locally delivered 1% metformin gel improves bone healing around immediately placed dental implants augmented with GBR.
Sponsor: Al-Azhar University • Aim: Disease control
Last updated Aug 20, 2026 00:00 UTC
-
A new strategy to help older adults with multiple health issues take control
Symptom relief CompletedApproximately 45% of older adults in the U.S. have 2 or more chronic health conditions (e.g., arthritis, hypertension, diabetes) in addition to functional limitations that prevent performance of health self-management activities. Self-management continues to be the gold standard …
Sponsor: University of Oklahoma • Aim: Symptom relief
Last updated Aug 22, 2026 00:00 UTC
-
Laser light before muscle shocks: a new way to cut fatigue?
Symptom relief CompletedNeuromuscular electrical stimulation (NMES) is effective for strength training and rehabilitation, but non-selective motor unit recruitment often induces rapid fatigue, discomfort, and muscle damage. Photobiomodulation therapy (PBMT) has been proposed to attenuate muscle fatigue …
Sponsor: Federal University of Rio Grande do Sul • Aim: Symptom relief
Last updated Sep 02, 2026 00:00 UTC
-
New hope for tough cancers: veonetinib trial launches
Disease control Recruiting nowThis trial is a Phase II trial designed to evaluate the safety and efficacy of using oral AL8326 , a multi-targeted receptor Tyrosine Kinase Inhibitor( TKI) , to recurrent, advanced, or metastatic small cell lung cancer (SCLC) patients , Non-Small Cell Lung (NSCLC) and Renal Cell…
Phase 2 • Sponsor: Advenchen Pharmaceuticals, LLC. • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
New drug shows promise for Long-Term fragile x management
Disease control OngoingThis is a 4-year, open-label extension (OLE) study for subjects completing one of two double-blind clinical trials with BPN14770, Study BPN14770-CNS-301 (in adult males) and Study BPN14770-CNS-204 (in adolescent males).
Phase 3 • Sponsor: Tetra Discovery Partners • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
New pacing technique may lower heart failure risk in pacemaker patients
Disease control Recruiting nowPROTECT-SYNC study is a multicenter, randomized, controlled trial. A total of 7 medical centers across Republic of Korea will enroll 450 patients during 2 years of enrollment period, and followed for 2 years of follow-up period. The purpose of this study to compare the clinical o…
Sponsor: Yonsei University • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
Plant protein swap may tame blood sugar in type 2 diabetes
Disease control Recruiting nowThe goal of this clinical trial is to examine the effect plant-based diet, with a partial replacement of animal protein by plant protein, in blood sugar levels and other health risks of people with type 2 diabetes and excessive weight. The plant-based diet will be compared to a s…
Sponsor: Hospital de Clinicas de Porto Alegre • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
3D printing may help doctors fix dangerous aortic bulges more safely
Disease control Recruiting nowthe comparison of physician-modified stent-graft created in 3D models versus custom-made devices in the treatment of complex abdominal aortic aneurysm
Sponsor: Samodzielny Publiczny Szpital Kliniczny nr 2 PUM • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Brain training shows promise for tic control in teens
Symptom relief Recruiting nowThis is a clinical trial where adolescents aged 10-16 years old with Tourette Syndrome (or chronic tic disorder) are randomized to receive either real-time functional magnetic resonance imaging (fMRI) neurofeedback targeting the supplementary motor area (for the experimental inte…
Sponsor: Yale University • Aim: Symptom relief
Last updated Jun 27, 2026 13:04 UTC